40
Participants
Start Date
October 11, 2024
Primary Completion Date
October 31, 2029
Study Completion Date
October 31, 2029
Collagenase Clostridium Histolyticum
"4 Series given to each participant, 6 weeks apart. Medication administered on back-to-back days. If failing to achieve an adequate response, men may receive up to 2 additional series 9-12 months after the 4th series.~Total of 0.9 mg administered with each series, diluted to 0.8 mL"
RestoreX
Restorex initiated beginning on post-injection day 3 or as soon as tolerated - 30 min daily, continuing until 6 weeks after final injection of the final CCH series.
Sildenafil
Men will be prescribed sildenafil 25 mg nightly beginning treatment day 2 until 6 weeks after final injection of the final series.
RECRUITING
Male Fertility and Peyronie's Clinic, Orem
Collaborators (1)
Endo Pharmaceuticals
INDUSTRY
Charitable Union for the Research and Education of Peyronie's Disease
OTHER